How would you approach a patient who responded to CDK4/6 inhibitor/endocrine therapy combination for metastatic HR+,HER2- breast cancer who now has disease progression which is biopsy proven TNBC?
Progression was observed only in the breast and required palliative mastectomy (T4b TNBC)
I respectfully disagree. If there are no metastas...
Thanks The scenario is: ER positive HER 2 negati...
You mention "one of the masses" progressing in the...
Denovo mets dz. Breast mass, ALN and lung bx - all...
Since she is already metastatic, your treatment is...
Now that we have these additional details, I agree...
Thank you everyone for your valuable input.